Granules India informs about press release

13 Dec 2023 Evaluate

Granules India has informed that it enclosed the press release titled ‘Granules India Limited Received ANDA Approval for Pantoprazole Sodium Delayed-Release Tablets’.

The above information is a part of company’s filings submitted to BSE.


Granules India Share Price

576.80 3.00 (0.52%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×